Literature DB >> 9552463

The effect of polyvinylpyrrolidine on the stability of taurolidine.

L E Kirsch1, Y S Sihn.   

Abstract

In an aqueous solution, taurolidine reversibly degrades to taurultam, hydroxymethyltaurultam, taurineamide, and formaldehyde. The objectives of this research were to investigate the mechanism of polyvinylpyrrolidine (PVP)-induced taurolidine stabilization by measuring the effect of PVP on the rate and extent of formaldehyde release from taurolidine and its decomposition products, the ionization of taurineamide, and the NMR and FT-IR spectra of taurineamide. PVP was found to a) increase the rate constant for taurultam formation from taurineamide and formaldehyde, b) decrease the apparent pKa of taurineamide, and c) alter the NMR and FT-IR taurineamide spectra. The effect of PVP on the stability of taurolidine was to increase the stability of its primary degradation product, taurultam, which, in turn increased taurolidine stability because taurultam was reversibly formed from taurolidine. Furthermore, the increased stability of taurultam in acidic, aqueous PVP solutions was due to an increased rate of taurultam formation from its primary degradation products: taurineamide and formaldehyde. The rate constant for taurultam formation increased three-fold in the presence of 5% PVP. The rate increase was caused by the interaction of unprotonated taurineamide with PVP. The estimated taurineamide-PVP association constant was 1800 M-1. This interaction decreased the concentration of unreactive/protonated taurineamide while increasing the concentration of unprotonated/associated substrate which was found to be fivefold less reactive than the free/unprotonated amine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9552463     DOI: 10.3109/10837459709022633

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  In-vitro effects of taurolidine alone and in combination with mitoxantrone and/or piroxicam on canine transitional cell carcinoma.

Authors:  Brittney Byer; Lisa J Schlein; Barbara Rose; Bernard Séguin
Journal:  Can J Vet Res       Date:  2020-04       Impact factor: 1.310

2.  The Antiseptic and Antineoplastic Agent Taurolidine Modulates Key Leukocyte Functions.

Authors:  Yannick Wouters; Gina R H Mennen; René H M Te Morsche; Hennie M J Roelofs; Geert J A Wanten
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

3.  Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.

Authors:  Kevin Marley; Stuart C Helfand; Jennifer Simpson; John E Mata; William G Tracewell; Lisa Brownlee; Shay Bracha; Bernard Séguin
Journal:  J Exp Clin Cancer Res       Date:  2013-10-11

4.  Salvage of Cardiac Implantable Electronic Device Pocket Infection with Skin Erosion in Frail 92-Year-Old.

Authors:  Marzia Giaccardi; Benito Baldauf; Ernest W Lau; Stefan Borov; Hendrik Bonnemeier
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.